Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 18 Jul 2022 for Immix Biopharma, Inc., €549.
Filing timeline
BuySaleSean Senn
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
Sean Senn: trading record in brief
All filings by Sean Senn on record concern Immix Biopharma, Inc. In total, 2 filings cover trades dated 14 July 2022.
Every open-market trade on record is a sale: 2 sales worth €1,097.
The latest filing, published on 22 July 2022, reports an open-market sale of €549 in Immix Biopharma, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sean Senn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 200 shares@ US$2.75100.0% of flowCommon StockSEC:0001493152-22-019731:0
1 of 1 declaration